<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Drugs currently recommended for leishmaniasis treatment include compounds such as pentavalent antimonials, amphotericin B, lipid formulations of amphotericin B (treatment of visceral leishmaniasis) and miltefosine, which is the only orally administered drug. However, there are some limitations regarding their toxicity, lack of efficacy, need and cost of hospitalization cost
 <sup class="sup">
  <xref rid="B4" ref-type="bibr" class="xref">4</xref>-
  <xref rid="B6" ref-type="bibr" class="xref">6</xref>
 </sup>. Other problems such as re-emerging infectious diseases and resistance to currently used drugs are widely recognized as being of serious and immediate concern. Thus, it is imperative to search for new drugs against 
 <italic class="italic">Leishmania</italic> parasites
 <sup class="sup">
  <xref rid="B7" ref-type="bibr" class="xref">7</xref>-
  <xref rid="B9" ref-type="bibr" class="xref">9</xref>
 </sup>.
</p>
